Financial Year |
March 31 2023 |
Monetary Funds |
2,067,369,693.53 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
750,477,216.34 |
Advances to Suppliers |
106,474,259.73 |
Other Receivables |
10,611,325.77 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
5,408,395.57 |
Dividend Receivable |
-- |
Inventories |
841,800,026.40 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
162,727,073.60 |
Other Current Assets |
41,636,630.01 |
Total Current Assets |
4,651,355,055.53 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
162,389,322.69 |
Investment Properties |
21,222,405.40 |
Fixed Assetes |
5,611,632,830.22 |
Under-construction Projects |
947,682,872.93 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
465,794,196.93 |
R&D expenses |
-- |
Goodwill |
503,431,800.46 |
Long-Term Deferred and Prepaid Expenses |
54,654,030.12 |
Deferred Income Tax Assets |
42,909,914.62 |
Other Non-Current Assets |
151,777,683.58 |
Sub-Total of Non-Current Assets |
8,037,025,858.74 |
Total Assets |
12,688,380,914.27 |
Short-Term Loans |
695,537,657.11 |
Trading Financial liabilities |
6,975,149.34 |
Notes Payable |
204,573,610.00 |
Accounts Payable |
904,739,197.00 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
27,857,742.21 |
Taxes Payable |
81,929,702.65 |
Interest Payable |
355,883.34 |
Dividend Payable |
-- |
Other payables |
351,590,938.81 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
6,884,617.28 |
Other Current Liabilities |
12,240,127.18 |
Sub-Total of Current Liabilities |
2,386,490,776.76 |
Long-term Loans |
4,000,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
16,189,098.38 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
111,779,160.20 |
Total Liabilities |
2,498,269,936.96 |
Paid-In Capital(Or Share Stock) |
1,401,945,207.00 |
Capital Surplus |
2,210,572,272.98 |
Surplus Reserve |
710,000,000.00 |
LESS:Treasury Stock |
100,346,263.23 |
Undistributed Profits |
5,923,085,090.53 |
Minority Stockholder's Interest |
29,970,177.46 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,160,140,799.85 |
Owner's Equity(Stockholder's Equity) |
10,190,110,977.31 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
12,688,380,914.27 |